Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|11|883-907

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.11, 2003-06, pp. : 883-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of aspartic proteases – potential antimalarial agents

By Boss Christoph   Corminboeuf Olivier   Grisostomi Corinna   Weller Thomas  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 295-317

Informa Healthcare

Access to resources Recommend Favorite

Three protease inhibitors have shown in vitro activity against the malaria-causing parasite Plasmodium falciparum

By  

Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets

By  

Current Drug Targets, Vol. 18, Iss. 14, 2017-10 ,pp. : 1676-1686

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Plasmodium falciparum Protease Inhibitors in the Past Decade (2002–2012)

By  

Current Medicinal Chemistry, Vol. 20, Iss. 25, 2013-08 ,pp. : 3049-3068

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR, Docking and ADMET Studies of Artemisinin Derivatives for Antimalarial Activity Targeting Plasmepsin II, a Hemoglobin-Degrading Enzyme from P. falciparum

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6133-6154

Bentham Science Publishers

Access to resources Recommend Favorite